scholarly journals Cu, Zn doped borate bioactive glasses: antibacterial efficacy and dose-dependent in vitro modulation of murine dendritic cells

2020 ◽  
Vol 8 (8) ◽  
pp. 2143-2155 ◽  
Author(s):  
Katharina Schuhladen ◽  
Lena Stich ◽  
Jochen Schmidt ◽  
Alexander Steinkasserer ◽  
Aldo R. Boccaccini ◽  
...  

Bioactive borate glasses additionally doped with copper and/or zinc have enthralling immune-modulatory effects on immune cells.

2017 ◽  
Vol 91 (6) ◽  
Author(s):  
Sarah E. Jackson ◽  
George X. Sedikides ◽  
Gavin M. Mason ◽  
Georgina Okecha ◽  
Mark R. Wills

ABSTRACT Human cytomegalovirus (HCMV) infection and periodic reactivation are generally well controlled by the HCMV-specific T cell response in healthy people. While the CD8+ T cell response to HCMV has been extensively studied, the HCMV-specific CD4+ T cell effector response is not as well understood, especially in the context of direct interactions with HCMV-infected cells. We screened the gamma interferon (IFN-γ) and interleukin-10 (IL-10) responses to 6 HCMV peptide pools (pp65, pp71, IE1, IE2, gB, and US3, selected because they were the peptides most frequently responded to in our previous studies) in 84 donors aged 23 to 74 years. The HCMV-specific CD4+ T cell response to pp65, IE1, IE2, and gB was predominantly Th1 biased, with neither the loss nor the accumulation of these responses occurring with increasing age. A larger proportion of donors produced an IL-10 response to pp71 and US3, but the IFN-γ response was still dominant. CD4+ T cells specific to the HCMV proteins studied were predominantly effector memory cells and produced both cytotoxic (CD107a expression) and cytokine (macrophage inflammatory protein 1β secretion) effector responses. Importantly, when we measured the CD4+ T cell response to cytomegalovirus (CMV)-infected dendritic cells in vitro, we observed that the CD4+ T cells produced a range of cytotoxic and secretory effector functions, despite the presence of CMV-encoded immune evasion molecules. CD4+ T cell responses to HCMV-infected dendritic cells were sufficient to control the dissemination of virus in an in vitro assay. Together, the results show that HCMV-specific CD4+ T cell responses, even those from elderly individuals, are highly functional and are directly antiviral. IMPORTANCE Human cytomegalovirus (HCMV) infection is carried for a lifetime and in healthy people is kept under control by the immune system. HCMV has evolved many mechanisms to evade the immune response, possibly explaining why the virus is never eliminated during the host's lifetime. The dysfunction of immune cells associated with the long-term carriage of HCMV has been linked with poor responses to new pathogens and vaccines when people are older. In this study, we investigated the response of a subset of immune cells (CD4+ T cells) to HCMV proteins in healthy donors of all ages, and we demonstrate that the functionality of CD4+ T cells is maintained. We also show that CD4+ T cells produce effector functions in response to HCMV-infected cells and can prevent virus spread. Our work demonstrates that these HCMV-specific immune cells retain many important functions and help to prevent deleterious HCMV disease in healthy older people.


2002 ◽  
Vol 70 (2) ◽  
pp. 1023-1026 ◽  
Author(s):  
Heather Jebbari ◽  
Andrew J. Stagg ◽  
Robert N. Davidson ◽  
Stella C. Knight

ABSTRACT Using an in vitro transwell migration assay, we have demonstrated that products secreted by Leishmania major promastigotes inhibit the motility of dendritic cells (DC) by up to 93%. Inhibition was dose dependent and reversible. By inhibiting DC migration in vivo, L. major may therefore subvert DC from their potentially protective role during leishmaniasis.


2018 ◽  
Vol 62 (8) ◽  
Author(s):  
Adepemi O. Ogundeji ◽  
Boitumelo F. Porotloane ◽  
Carolina H. Pohl ◽  
Pravin S. Kendrekar ◽  
Olihile M. Sebolai

ABSTRACTThein vitroantifungal activity of aspirin against cryptococcal cells has been reported. However, the unwanted effects of aspirin may limit its clinical application. Conceivably, a derivative of aspirin could overcome this challenge. Toward this end, this study considered the usage of an aspirinate-metal complex, namely, copper acyl salicylate (CAS), as an anti-Cryptococcusantifungal agent. Additionally, the study examined the effects of this compound on macrophage function. Thein vitrosusceptibility results revealed that cryptococcal cells were vulnerable (in a dose-dependent manner) to CAS, which might have effected growth inhibition by damaging cryptococcal cell membranes. Interestingly, when CAS was used in combination with fluconazole or amphotericin B, synergism was observed. Furthermore, CAS did not negatively affect the growth or metabolic activity of macrophages; rather, it sensitized those immune cells to produce interferon gamma and interleukin 6, which, in turn, might have aided in the phagocytosis of cryptococcal cells. Compared to our aspirin data, CAS was noted to be more effective in killing cryptococcal cells (based on susceptibility results) and less toxic toward macrophages (based on growth inhibition results). Taking these findings together, it is reasonable to conclude that CAS may be a better anti-Cryptococcusdrug that could deliver better therapeutic outcomes, compared to aspirin.


2019 ◽  
Vol 9 (1) ◽  
Author(s):  
Kosuke Nishi ◽  
Yoshiki Kanayama ◽  
In-Hae Kim ◽  
Akihiro Nakata ◽  
Hisashi Nishiwaki ◽  
...  

Abstract Docosahexaenoic acid (DHA) is a long-chain polyunsaturated fatty acid mainly found in fish oil. Although several studies have suggested that it can alleviate allergy symptoms, its mechanism of action remains to be elucidated. In the present study, we found that docosahexaenoyl ethanolamide (DHEA), a metabolite of DHA produced in the human body, exerts the anti-allergic activity in vitro and in vivo. DHEA suppressed degranulation of rat basophilic leukemia RBL-2H3 cells and bone marrow-derived mast cells in a dose-dependent manner without cytotoxicity. This occurred due to a decrease in Ca2+ influx, which is critical for mast cell degranulation. DHEA also suppressed IgE-mediated passive cutaneous anaphylaxis reaction in mice. In addition, DHEA was demonstrated to lessen an allergic symptom in a mouse model of pollinosis and to alter the production of IgE and cytokines secreted by splenocytes collected from the pollinosis mice. Taken together, this study indicates that DHEA is a promising anti-allergic agent as it inhibits mast cell degranulation and modulates other immune cells.


Nanomedicine ◽  
2019 ◽  
Vol 14 (23) ◽  
pp. 3013-3033 ◽  
Author(s):  
José Crecente-Campo ◽  
Tommaso Virgilio ◽  
Diego Morone ◽  
Cristina Calviño-Sampedro ◽  
Iago Fernández-Mariño ◽  
...  

Aim: To design lympho-targeted nanocarriers with the capacity to enhance the activity of associated drugs/antigens whose target is within the lymphatic system. Materials & methods: Inulin (INU)-based nanocapsules (NCs), negatively charged and positively charged chitosan NCs were prepared by the solvent displacement techniques. The NCs were produced in two sizes: small (70 nm) and medium (170–250 nm). Results: In vitro results indicated that small NCs interacted more efficiently with dendritic cells than the larger ones. The study of the NCs biodistribution in mice, using 3D reconstruction of the popliteal lymph node, showed that small INU NCs have the greatest access and uniform accumulation in different subsets of resident immune cells. Conclusion: Small and negatively charged INU NCs have a potential as lympho-targeted antigen/drug nanocarriers.


2021 ◽  
Vol 11 ◽  
Author(s):  
Qihang Hou ◽  
Jingxi Huang ◽  
Hammed Ayansola ◽  
Hori Masatoshi ◽  
Bingkun Zhang

The mammalian intestine is the largest immune organ that contains the intestinal stem cells (ISC), differentiated epithelial cells (enterocytes, Paneth cells, goblet cells, tuft cells, etc.), and gut resident-immune cells (T cells, B cells, dendritic cells, innate lymphoid cell, etc.). Inflammatory bowel disease (IBD), a chronic inflammatory disease characterized by mucosa damage and inflammation, threatens the integrity of the intestine. The continuous renewal and repair of intestinal mucosal epithelium after injury depend on ISCs. Inflamed mucosa healing could be a new target for the improvement of clinical symptoms, disease recurrence, and resection-free survival in IBD treated patients. The knowledge about the connections between ISC and immune cells is expanding with the development of in vitro intestinal organoid culture and single-cell RNA sequencing technology. Recent findings implicate that immune cells such as T cells, ILCs, dendritic cells, and macrophages and cytokines secreted by these cells are critical in the regeneration of ISCs and intestinal epithelium. Transplantation of ISC to the inflamed mucosa may be a new therapeutic approach to reconstruct the epithelial barrier in IBD. Considering the links between ISC and immune cells, we predict that the integration of biological agents and ISC transplantation will revolutionize the future therapy of IBD patients.


Blood ◽  
2007 ◽  
Vol 110 (11) ◽  
pp. 4902-4902
Author(s):  
Yin Liang ◽  
Lily Lien ◽  
Shuhong Han ◽  
Chun-Rong Tong ◽  
Zhi-Yong Gao ◽  
...  

Abstract Cancer-specific cytotoxic T lymphocytes (CTL) have great potential in cancer immunotherapy. We performed a longitudinal study of CTL primed with dendritic cells (DC) exposed to leukemic antigens or DC directly differentiated from leukemic cells in an acute myeloid leukemia (AML) patient. The patient received three HLA locus-mismatched allogeneic bone marrow transplantation, relapsed around day 43, and after a brief remission, suffered an ongoing multi-focal extramedullary relapse. CTL generated against AML cells early during the course of disease (early-AML) effectively targeted the early-AML cells as demonstrated by in vitro CTL assays. The patient received multiple infusions of immune cells specific to the early-AML cells in a pilot trial. While the patient established stable remission in the peripheral blood, extensive extramedullary relapse had occurred. The CTL prepared from DC exposed to the early-AML cells failed to target the late relapsed AML (late-AML) cells isolated from pleural effusion and peripheral blood. Further characterization of the late-AML cells showed complete and partial loss of class II and class I HLA expression, respectively. Interestingly, CTL prepared from the late-AML-derived DC were able to kill the late relapsed cancer cells. This result suggests that the late-AML cells, although escaped from the early-AML-derived CTL, expressed novel immunogenic leukemic antigens. It appeared that selective growth of AML cells resistant to the early-AML-specific immune cells had occurred in vivo. However, CTL primed with the late-AML-derived DC were able to kill the late relapsed cancer cells in vitro. Thus, AML could evolve in vivo under active immunotherapy, but this may be coped with preparation of cancer-specific immune cells using the late-AML cells.


1976 ◽  
Vol 35 (02) ◽  
pp. 350-357 ◽  
Author(s):  
Hana Bessler ◽  
Galila Agam ◽  
Meir Djaldetti

SummaryA three-fold increase of protein synthesis by human platelets during in vitro phagocytosis of polystyrene latex particles was detected. During the first two hours of incubation, the percentage of phagocytizing platelets and the number of latex particles per platelet increased; by the end of the third hour, the first parameter remained stable, while the number of latex particles per cell had decreased.Vincristine (20 μg/ml of cell suspension) inhibited platelet protein synthesis. This effect was both time- and dose-dependent. The drug also caused a decrease in the number of phagocytizing cells, as well as in their phagocytotic activity.


1966 ◽  
Vol 15 (03/04) ◽  
pp. 349-364 ◽  
Author(s):  
A.H Özge ◽  
H.C Rowsell ◽  
H.G Downie ◽  
J.F Mustard

SummaryThe addition of trace amounts of adrenaline to whole blood in plasma in vitro increased factor VIII, factor IX and whole plasma activity in the thromboplastin generation test. This was dose dependent.Adrenaline infusions less than 22 (μg/kg body weight in normal dogs accelerated clotting, increased factor IX, factor VIII and whole plasma activity in the thromboplastin generation test and caused a fall in blood pH. In a factor IX deficient dog, there was no increase in factor IX activity. After adrenaline infusions, however, the other changes occurred and were of the same order of magnitude as in the normal. Adrenaline in doses greater than 22 μg/kg body weight did not produce as great an effect on clotting in normal or factor IX deficient dogs. The platelet count in the peripheral blood was increased following the infusion of all doses of adrenaline. These observations suggest that the accelerating effect of adrenaline on clotting is not mediated through increase in activity of a specific clotting factor.


Sign in / Sign up

Export Citation Format

Share Document